For patients with chronic kidney disease and type 2 diabetes, combination finerenone plus empagliflozin leads to a greater ...

Phase II CONFIDENCE study data reveal that simultaneous initiation of Kerendia and Jardiance significantly improves UACR and ...

Prompt treatment with a drug combo can effectively manage chronic kidney disease in people with type 2 diabetes, a new ...

Simultaneous treatment start with finerenone and SGLT-2-inhibitor demonstrated positive data in patients with CKD associated with type 2 diabetes: Berlin Saturday, June 7, 2025, 1 ...

Adults with chronic kidney disease and type 2 diabetes had slower kidney function decline with a combination of the ...

The standard of care for managing patients with type 2 diabetes and CKD -- in addition to a healthy lifestyle -- has always ...

New data from the CONFIDENCE trial demonstrates that combination therapy with finerenone and empagliflozin leads to ...

Subjects and methods: The study included 100 Egyptian subjects (50 patients with NAFLD with no history of diabetes or hypertension and 50 age and sex-matched normal healthy control subjects). Urine ...

supereva.it Objectives: To document the relation between serum creatinine concentration and body mass index in elite athletes from five different sports, and to study potential differences among ...

Diabetic kidney disease, a major complication for those with diabetes, can be prevented through proactive measures. Optimal ...

Type 2 diabetes was defined as patients discharged from hospital ... major cardiovascular event; uACR, urinary albumin-to-creatinine ratio. As shown in figure 2, patients with macroalbuminuria ...